Signaling networks in human hepatocarcinogenesis: novel aspects and therapeutic options

Hepatocellular carcinoma (HCC) represents one of the most common human malignancies with poor prognosis. Because therapeutic strategies are insufficient for most HCC patients, there is a great need to determine the central molecular mechanisms and pathways in order to derive novel targets for system...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Breuhahn, Kai (VerfasserIn) , Schirmacher, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 11 November 2010
In: Progress in molecular biology and translational science
Year: 2010, Jahrgang: 97, Pages: 251-277
ISSN:1878-0814
DOI:10.1016/B978-0-12-385233-5.00009-X
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/B978-0-12-385233-5.00009-X
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/B978012385233500009X
Volltext
Verfasserangaben:K. Breuhahn, P. Schirmacher

MARC

LEADER 00000caa a2200000 c 4500
001 1837791473
003 DE-627
005 20230710155020.0
007 cr uuu---uuuuu
008 230301s2010 xx |||||o 00| ||eng c
024 7 |a 10.1016/B978-0-12-385233-5.00009-X.  |2 doi 
035 |a (DE-627)1837791473 
035 |a (DE-599)KXP1837791473 
035 |a (OCoLC)1389821533 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Breuhahn, Kai  |d 1969-  |e VerfasserIn  |0 (DE-588)122803329  |0 (DE-627)082164959  |0 (DE-576)293427364  |4 aut 
245 1 0 |a Signaling networks in human hepatocarcinogenesis  |b novel aspects and therapeutic options  |c K. Breuhahn, P. Schirmacher 
264 1 |c 11 November 2010 
300 |a 27 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 01.03.2023 
520 |a Hepatocellular carcinoma (HCC) represents one of the most common human malignancies with poor prognosis. Because therapeutic strategies are insufficient for most HCC patients, there is a great need to determine the central molecular mechanisms and pathways in order to derive novel targets for systemic therapy. There is vast evidence that not only the dysregulation of distinct signaling cascades, but also their interactions at different levels, affect tumor cell function. Through these interactions, the effects of pathways can be increased, and even new tumor-supporting qualities acquired that further facilitate HCC progression. Although several approaches for the modulation of these relevant pathways are under development, future therapeutic strategies should take into account that oncogenic stimuli cannot be understood in a monodimensional manner. In order to avoid escape mechanisms during therapy, strategies based on comprehensive knowledge of the interactive regulatory network in hepatocarcinogenesis are necessary. 
650 4 |a Cross talk 
650 4 |a Growth factor 
650 4 |a Hepatocarcinogenesis 
650 4 |a Inhibitor 
650 4 |a Liver cancer 
650 4 |a Network 
650 4 |a p53 
650 4 |a Prostaglandin 
650 4 |a Tyrosine kinase 
700 1 |a Schirmacher, Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1020440112  |0 (DE-627)691221197  |0 (DE-576)360427448  |4 aut 
773 0 8 |i Enthalten in  |t Progress in molecular biology and translational science  |d Amsterdam [u.a.] : Elsevier, 2008  |g 97(2010), Seite 251-277  |h Online-Ressource  |w (DE-627)590279548  |w (DE-600)2474898-5  |w (DE-576)401632350  |x 1878-0814  |7 nnas  |a Signaling networks in human hepatocarcinogenesis novel aspects and therapeutic options 
773 1 8 |g volume:97  |g year:2010  |g pages:251-277  |g extent:27  |a Signaling networks in human hepatocarcinogenesis novel aspects and therapeutic options 
856 4 0 |u https://doi.org/10.1016/B978-0-12-385233-5.00009-X  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/B978012385233500009X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230301 
993 |a Article 
994 |a 2010 
998 |g 1020440112  |a Schirmacher, Peter  |m 1020440112:Schirmacher, Peter  |d 910000  |d 912000  |e 910000PS1020440112  |e 912000PS1020440112  |k 0/910000/  |k 1/910000/912000/  |p 2  |y j 
998 |g 122803329  |a Breuhahn, Kai  |m 122803329:Breuhahn, Kai  |d 910000  |d 912000  |d 50000  |e 910000PB122803329  |e 912000PB122803329  |e 50000PB122803329  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1837791473  |e 4281362665 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 01.03.2023"],"relHost":[{"title":[{"title_sort":"Progress in molecular biology and translational science","title":"Progress in molecular biology and translational science"}],"pubHistory":["Nachgewiesen 84.2008 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 13.05.11"],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"251-277","volume":"97","extent":"27","text":"97(2010), Seite 251-277","year":"2010"},"origin":[{"publisher":"Elsevier","dateIssuedKey":"2008","dateIssuedDisp":"2008-","publisherPlace":"Amsterdam [u.a.]"}],"id":{"zdb":["2474898-5"],"issn":["1878-0814"],"eki":["590279548"]},"disp":"Signaling networks in human hepatocarcinogenesis novel aspects and therapeutic optionsProgress in molecular biology and translational science","recId":"590279548"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"27 S."}],"title":[{"title_sort":"Signaling networks in human hepatocarcinogenesis","title":"Signaling networks in human hepatocarcinogenesis","subtitle":"novel aspects and therapeutic options"}],"person":[{"display":"Breuhahn, Kai","role":"aut","given":"Kai","family":"Breuhahn"},{"display":"Schirmacher, Peter","given":"Peter","role":"aut","family":"Schirmacher"}],"recId":"1837791473","name":{"displayForm":["K. Breuhahn, P. Schirmacher"]},"origin":[{"dateIssuedDisp":"11 November 2010","dateIssuedKey":"2010"}],"id":{"eki":["1837791473"],"doi":["10.1016/B978-0-12-385233-5.00009-X."]}} 
SRT |a BREUHAHNKASIGNALINGN1120